Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for PBH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2004. Start Trial.
Date Value
June 30, 2026 89.13M
March 31, 2026 63.87M
December 31, 2025 62.37M
September 30, 2025 119.11M
June 30, 2025 139.50M
March 31, 2025 97.88M
December 31, 2024 50.87M
September 30, 2024 51.54M
June 30, 2024 34.26M
March 31, 2024 46.47M
December 31, 2023 63.62M
September 30, 2023 60.07M
June 30, 2023 54.58M
March 31, 2023 58.49M
December 31, 2022 86.36M
September 30, 2022 42.44M
June 30, 2022 35.87M
March 31, 2022 27.18M
December 31, 2021 21.02M
September 30, 2021 42.82M
June 30, 2021 163.62M
March 31, 2021 32.30M
December 31, 2020 62.10M
September 30, 2020 26.60M
June 30, 2020 57.94M
Date Value
March 31, 2020 94.76M
December 31, 2019 28.59M
September 30, 2019 27.90M
June 30, 2019 29.04M
March 31, 2019 27.53M
December 31, 2018 24.67M
September 30, 2018 36.91M
June 30, 2018 34.27M
March 31, 2018 32.55M
December 31, 2017 45.38M
September 30, 2017 42.98M
June 30, 2017 44.14M
March 31, 2017 41.86M
December 31, 2016 63.29M
September 30, 2016 30.46M
June 30, 2016 28.88M
March 31, 2016 27.23M
December 31, 2015 48.97M
September 30, 2015 22.15M
June 30, 2015 21.60M
March 31, 2015 21.32M
December 31, 2014 21.95M
September 30, 2014 21.75M
June 30, 2014 15.68M
March 31, 2014 28.33M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Indivior Pharmaceuticals, Inc. 222.00M
ANI Pharmaceuticals, Inc. 375.87M
Corcept Therapeutics, Inc. 308.20M
Veru, Inc. 25.79M
Johnson & Johnson 20.76B